UNSPSC 51121921: G-strophanthin or ouabain

This classification denotes a cardiotonic agent and enzyme inhibitor with the molecular formula C29H44O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5ACL011P69, chemically known as 3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide but generally known as g-strophanthin, which bears US NIH Compound Identifier 4605. World Health Organization schedules g-strophanthin in its Anatomical Therapeutic Chemical (ATC) Classification.

SMILES: CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O.

UNSPSC 51121921 G-strophanthin or ouabain, a Commodity code, nominally covers cardiac glycoside injections but sees minimal direct state and local procurement activity under this specific drug name. Recent solicitations tagged to this code reflect broader emergency-medicine and pharmacy-benefit procurement rather than procurement of the named compound itself. State and local buying under related cardiac-medication codes spans emergency life-support drugs supplied to fire rescue services, hospital networks, and state pharmacy benefit programs. Issuing bodies include city purchasing departments (Tampa Fire Rescue), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving member jurisdictions across multiple states including Oregon). The work entails supplying pre-packaged injectable medications with regulated expiration windows, maintaining cold-chain compliance, handling hazardous-material documentation per OSHA standards, and integrating with state pharmacy-benefit networks and wholesaler distribution channels.

Recent activity appears concentrated in Florida, Texas, and the Upper Midwest. The City of Tampa's Purchasing Department issued an IFB (26P00188) for Advanced Life Support Medications due April 8, 2026, seeking 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and other cardiac drugs for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market set-aside offering a 5 percent discount. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 exploring direct-to-manufacturer prescription programs and vendor capabilities for state pharmacy benefit implementation, signaling future formal procurement once market research concludes. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with contract effectiveness July 1, 2026, and a two-year initial term. Vendors responding to these solicitations must manage FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, insurance minimums between $2 million and $5 million, and integration with state wholesaler networks and chargeback systems.